ESC Premium Access

Potential for bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes

Congress Session

About the speaker

Doctor Sarah L Ayton

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)
0 follower

14 more presentations in this session

Vascular access devices (VADs), vascular closure devices (VCDs) and hemorrhagic complications - real-life study in our hospital

Speaker: Mr F. Moniz Mendonca (Funchal, PT)

Thumbnail

Gender-related association between traditional risk factors and obstructive coronary artery disease in stable symptomatic patients

Speaker: Doctor J. Park (Seoul, KR)

Thumbnail

The impact of revascularization by elective percutaneous coronary intervention on autonomic modulation assessed by heart rate variability

Speaker: Doctor M. Abdelnabi (Lubbock, US)

Thumbnail

The impact of thyriod hormones on the prognosis of coronary heart disease patients with subclinical hypothyroidism in SYNTAXII system

Speaker: Professor R. Huang (Beijing, CN)

Thumbnail

Substantial international variation in patterns of investigation for patients with suspected unstable angina - a TRAPID-AMI substudy

Speaker: Doctor C. Reynard (Manchester, GB)

Thumbnail

Access the full session

Poster Session 4 - Coronary artery disease miscellaneous

Speakers: Doctor S. Ayton, Mr F. Moniz Mendonca, Doctor J. Park, Doctor M. Abdelnabi, Professor R. Huang...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk